Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: CellCept wins orphan status

By admin

Created Jan 3 2006 - 7:01pm

The FDA has granted orphan drug status to the immunosuppressant CellCept, being developed by Roche and Aspreva. CellCept is currently in a late-stage trial for Myasthenia Gravis, a rare immune system ailment. Report [1]

Drug Trials
FDA
immune system
orphan drug status
Roche

Source URL: http://www.fiercebiotech.com/story/spotlight-cellcept-wins-orphan-status/2006-01-04

Links:
[1] http://www.forbes.com/markets/feeds/afx/2006/01/03/afx2425323.html